Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

FrontFour Capital Is After Innophos

by Alexander H. Tullo
October 13, 2014 | A version of this story appeared in Volume 92, Issue 41

The activist shareholder FrontFour Capital has phosphorus chemicals maker Innophos Holdings in its sights. FrontFour sent a letter to Innophos executives demanding that they raise dividends, repurchase more shares, and consider selling their company, in whole or in part. In particular, FrontFour would like to see the company divest its cyclical phosphate fertilizer business and focus on food and beverage applications. And given the high values that similar companies are garnering, FrontFour thinks Innophos’s managers should explore a sale of the firm as well. In the letter, FrontFour executives say they left an Aug. 14 meeting with Innophos with the impression that the firm may instead “pursue an expensive, value-destructive acquisition.” Innophos responds that it will pursue a strategy in its own best interest. FrontFour, which owns a 3.3% stake in Innophos, previously targeted the chemical makers Ferro and Sensient Technologies, both of which responded with restructuring actions.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.